By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Researchers pinpoint what happens on a cellular and molecular level over time when the cancer is treated with either ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions continue to assist pulmonologists.

Quality-of-life in lung cancer varies, with certain treatments leading to sleep-related issues, pain, and emotional changes ...

During a live event, Christine Bestvina, MD, reviewed outcomes from the phase 3 KRYSTAL-12 and CodeBreak 200 trials in the ...

Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...